2006 Best of Show Winning Products


May 12, 2006

Protecting What Matters
Revivio’s Continuous Protection System (CPS) is a continuous data protection solution that allows companies to eliminate their backup windows, restore data instantly, exactly as it existed at any point or event in time, and recover business applications in minutes. The company’s Application Integration Suite software fully automates all aspects of recovery, from restoring e-mails and files to testing complex remote disaster recovery capabilities. It also assures compliance with disaster recovery plans, creating a seamless and transparent portal between primary and secondary storage. Application-specific knowledge modules enable automated data protection for an array of applications, including PACS, McKesson Horizon, and Lawson Financial systems, as well as Oracle, Sybase, and MS-SQL databases.
Vendor: Revivio
Product: Continuous Protection System
Availability: Now
For more information: (781) 301-0200; www.revivio.com

Phasing Forward with CTSD
Phase Forward’s Clinical Trials Signal Detection (CTSD) system, combines tools for early detection and characterization of potential safety problems with a standards-based repository for clinical trials data. Built upon Lincoln Technologies’ WebSDM electronic data submission platform, which was developed in conjunction with the FDA, CTSD integrates data from clinical trials into a CDISC SDTM-compliant data repository and then performs automated screening on it for potential safety issues. Other capabilities include the ability to identify adverse events related to study drugs, evaluate ECG data to detect possible QT prolongation, pool data across studies, and manage and track signals.
Vendor: Phase Forward
Product: Clinical Trials Signal Detection system
Availability: Now
For more information: www.phaseforward.com

Finding the Functionality with MedScan
Ariadne’s advanced information extraction technology, MedScan, can initiate and facilitate the growth of biomedical Semantic Web content. MedScan utilizes a high-content linguistics approach to extract functional relationships between proteins, cell processes, and small molecules. It recognizes types of regulatory mechanisms involved and the effects of regulation and can be customized to extract other types of information. Other key features include handcrafted dictionaries of protein and chemical names; a Natural Language Processing engine, specifically targeted to the language of biomedical publications; fast algorithms, allowing for fine-tuning of queries and receiving results on-the-fly; and customizable and extendable rules for information extraction.
Vendor: Ariadne Genomics
Product: MedScan
Availability: Now
For more information: (866) 340-5040; www.ariadnegenomics.com

Discovering Knowledge with Nervana’s Discovery Solution
The Nervana Discovery Solution provides knowledge workers with the ability to ask questions “naturally” within the context of the meaning — in ways they never could before — crossing multiple domains and information repositories. The Nervana engine correlates all the possible combinations of meaning for the request and returns the most relevant, timely results from the system. Knowledge workers are immediately empowered with insight and information from unexpected connections they’ve never experienced before with existing search technologies. The Nervana Discovery Solution 3.0 offers a more personalized experience, allowing users to express their intended meaning, choose types of information, browse results by personal relevance and timeliness, as well as collaborate on knowledge discovery with others.
Vendor: Nervana
Product: Nervana Discovery Solution
Availability: Now
For more information: (866) 637-8262 (NERVANA); www.nervana.com

Back to main article.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.